• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scandidos

0.86 SEK

0.00 %

Less than 1K followers

SDOS

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-12.24 %
-12.07 %
-27.73 %
-23.89 %
-39.01 %
-61.95 %
-78.61 %
-93.78 %

Scandidos operates in the medical technology sector. The company offers products and systems for quality assurance of advanced radiation therapy for cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.

Read more
Market cap
49.03M SEK
Turnover
34.99K SEK
Revenue
61.84M
EBIT %
0.99 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16/6
2026

Extraordinary general meeting '27

17/6
2026

Annual report '26

17/9
2026

Interim report Q1'27

Regulatory press release6/2/2026, 12:15 PM

Kallelse till extra bolagsstämma i ScandiDos AB (publ)

Scandidos
Regulatory press release6/2/2026, 6:30 AM

Styrelsen i ScandiDos AB föreslår en företrädesemission om 12,8 MSEK för lansering av Delta4 SRS Pro

Scandidos
Press release5/15/2026, 6:00 AM

ScandiDos presenterar Delta4 SRS Pro på ESTRO 2026: Sätter en ny standard för stereotaktisk kvalitetssäkring.

Scandidos

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/15/2026, 6:00 AM

ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA

Scandidos
Regulatory press release5/6/2026, 12:00 PM

Anders Murman utses till tillförordnad VD för ScandiDos

Scandidos
Regulatory press release5/6/2026, 12:00 PM

Anders Murman appointed Acting CEO of ScandiDos

Scandidos
Regulatory press release3/18/2026, 7:00 AM

ScandiDos AB - Delårsrapport 1 maj 2025 – 31 jan 2026

Scandidos
Regulatory press release12/16/2025, 7:00 AM

ScandiDos AB - Delårsrapport 1 maj 2025 – 31 okt 2025

Scandidos
Regulatory press release11/28/2025, 10:00 AM

Uttalande från styrelsen i ScandiDos AB (publ) med anledning av budpliktserbjudandet från Spore Invest AB

Scandidos
Press release10/27/2025, 6:15 PM

Scandidos informerar om att Spore Invest AB har passerat gränsen för budplikt

Scandidos
Regulatory press release10/23/2025, 3:45 PM

KOMMUNIKÉ FRÅN ÅRSSTÄMMA I SCANDIDOS AB (PUBL)

Scandidos
Regulatory press release9/24/2025, 6:30 AM

ScandiDos AB Årsredovisning 2024/2025

Scandidos
Regulatory press release9/24/2025, 6:00 AM

KALLELSE TILL ÅRSSTÄMMA I SCANDIDOS AB (PUBL)

Scandidos
Regulatory press release9/18/2025, 6:00 AM

ScandiDos AB - Delårsrapport 1 maj 2025 – 31 jul 2025

Scandidos
Regulatory press release8/29/2025, 8:30 AM

ScandiDos AB byter Certified Adviser till Tapper Partners AB

Scandidos
Regulatory press release6/18/2025, 6:00 AM

ScandiDos AB - Bokslutskommuniké 1 maj 2024 – 30 apr 2025

Scandidos
Regulatory press release3/12/2025, 7:00 AM

ScandiDos AB - Delårsrapport 1 maj 2024 – 31 jan 2025

Scandidos
Regulatory press release12/17/2024, 7:00 AM

ScandiDos AB - Delårsrapport 1 maj 2024 – 31 okt 2024

Scandidos
Press release11/21/2024, 9:25 AM

ScandiDos expanderar med nytt referenscenter i Madrid, Spanien

Scandidos
Press release11/21/2024, 9:20 AM

ScandiDos Expands with New Reference Center in Madrid, Spain

Scandidos